IIQ Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation - 29th Jun 2023, 10:48am

annb0t

annb0t

Top 20
IIQ Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation
Price Sensitive: Y
Date: 29th Jun 2023, 10:48am

>>> Read announcement: Google: IIQ Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
IIQ Ann: SubB2M Breast Cancer Test Results Webinar Recording - 3rd Jul 2023, 3:02pm
Replies
0
Views
83
annb0t
annb0t
annb0t
IIQ Ann: Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test - 27th Jun 2023, 9:15am
Replies
0
Views
124
annb0t
annb0t
annb0t
IIQ Ann: Positive results for SubB2M Breast Cancer Test - 8th Feb 2023, 10:02am
Replies
0
Views
119
annb0t
annb0t
annb0t
IIQ Ann: INOVIQ to Develop SubB2M-Based Test on Nicoya SPR Platform - 13th Oct 2022, 9:39am
Replies
0
Views
147
annb0t
annb0t
annb0t
IIQ Ann: Positive SubB2M IHC Results for Melanoma - 26th Jul 2022, 10:19am
Replies
0
Views
188
annb0t
annb0t
Top Bottom